BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9338008)

  • 1. beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.
    Huang QS; Valyi-Nagy T; Kesari S; Fraser NW
    Gene Ther; 1997 Aug; 4(8):797-807. PubMed ID: 9338008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs.
    Margolis TP; Bloom DC; Dobson AT; Feldman LT; Stevens JG
    Virology; 1993 Dec; 197(2):585-92. PubMed ID: 8249281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
    Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
    Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
    Zhu J; Kang W; Wolfe JH; Fraser NW
    Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1.
    Huang QS; Deshmane SL; Fraser NW
    Gene Ther; 1994 Sep; 1(5):300-6. PubMed ID: 7584095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
    Branco FJ; Fraser NW
    J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice.
    Wolfe JH; Deshmane SL; Fraser NW
    Nat Genet; 1992 Aug; 1(5):379-84. PubMed ID: 1338772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.
    Akhmametyeva EM; Mihaylova MM; Luo H; Kharzai S; Welling DB; Chang LS
    Dev Dyn; 2006 Oct; 235(10):2771-85. PubMed ID: 16894610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term promoter activity during herpes simplex virus latency.
    Lokensgard JR; Bloom DC; Dobson AT; Feldman LT
    J Virol; 1994 Nov; 68(11):7148-58. PubMed ID: 7933097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.
    Bertke AS; Patel A; Krause PR
    J Virol; 2007 Jun; 81(12):6605-13. PubMed ID: 17409161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAT expression during an acute HSV infection in the mouse.
    Jarman RG; Wagner EK; Bloom DC
    Virology; 1999 Sep; 262(2):384-97. PubMed ID: 10502517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
    Cook SD; Paveloff MJ; Doucet JJ; Cottingham AJ; Sedarati F; Hill JM
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1558-61. PubMed ID: 1849874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.
    Krause PR; Croen KD; Ostrove JM; Straus SE
    J Clin Invest; 1990 Jul; 86(1):235-41. PubMed ID: 2365817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation.
    Deshmane SL; Nicosia M; Valyi-Nagy T; Feldman LT; Dillner A; Fraser NW
    Virology; 1993 Oct; 196(2):868-72. PubMed ID: 8396815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region.
    Naito J; Mukerjee R; Mott KR; Kang W; Osorio N; Fraser NW; Perng GC
    Virus Res; 2005 Mar; 108(1-2):101-10. PubMed ID: 15681060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1.
    Taus NS; Mitchell WJ
    J Virol; 2001 Nov; 75(21):10401-8. PubMed ID: 11581408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.